Accsys Technologies announces completion of INEOS subscription

Accsys Technologies, which recently announced a 50:50 joint venture with NEOS Industries Holdings, has announced the completion of INEOS's subscription for 23.53m shares in Accsys at 0.17 euro per share.

Accsys Technologies, which recently announced a 50:50 joint venture with NEOS Industries Holdings, has announced the completion of INEOS's subscription for 23.53m shares in Accsys at 0.17 euro per share.

The two companies have formed a new joint venture company, Tricoya Technologies, which has been formed to develop and exploit Accsys' Tricoya technology for use within MDF, particle board and wood plastic composites.

Paul Clegg, Accsys' Chief Executive Officer, said: "We are very pleased and encouraged to be able to welcome INEOS, a global petrochemical player and a global leader in the field of technology development and licensing, as a significant shareholder in Accsys.

"This €4.0m investment, together with INEOS's commitment to the Tricoya Technologies Limited joint venture strengthens Accsys' position as the undisputed world leaders in wood modification technology and enhances our ability to deliver value from our technology platform."

NR

Recommended

Share tips of the week – 19 August
Share tips

Share tips of the week – 19 August

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
19 Aug 2022
How to invest in smart factories as the “fourth industrial revolution” arrives
Share tips

How to invest in smart factories as the “fourth industrial revolution” arrives

Exciting new technologies and trends are coming together to change the face of manufacturing. Matthew Partridge looks at the companies that will drive…
18 Aug 2022
How to invest today? Look to the past, not the future
Investment strategy

How to invest today? Look to the past, not the future

The past few years have seen so many changes to our way of life that many people said we had entered a “new normal”. But as it turns out, the new norm…
18 Aug 2022
A new legal headache for Haleon
Stocks and shares

A new legal headache for Haleon

Haleon, GSK’s former consumer-products arm, spun off last month, has made a dismal debut on the stockmarket.
17 Aug 2022

Most Popular

How to protect your wealth as inflation hits new record highs
Investment strategy

How to protect your wealth as inflation hits new record highs

UK inflation has hit a new record high of 10.1%. It's going to hurt, says Dominic Frisby. Here's how you can protect your wealth.
17 Aug 2022
How to cut your energy bill
Personal finance

How to cut your energy bill

The energy-price cap will almost double in the autumn. What does this mean for your money, and how can you alleviate the squeeze? Ruth Jackson-Kirby h…
17 Aug 2022
Are GSK’s legal troubles a threat to the firm’s survival?
Biotech stocks

Are GSK’s legal troubles a threat to the firm’s survival?

Pharmaceutical giant GlaxoSmithKline is facing legal action over heartburn drug Zantac that has seen billions wiped off its market value. Rupert Hargr…
16 Aug 2022